Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    nct01429350
Show Display Options
Rank Status Study
1 Active, not recruiting Assess the Penumbra System in the Treatment of Acute Stroke
Condition: Ischemic Stroke
Interventions: Drug: intravenous (IV) recombinant human tissue plasminogen activator (rtPA);   Device: Penumbra System

Indicates status has not been verified in more than two years